Skip to content
The Policy VaultThe Policy Vault

Mytesi (crofelemer)Point32Health

Symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy

Preferred products

  • Anti-retroviral therapy (as listed on formulary)

Initial criteria

  • Medication requested is for the symptomatic relief of non-infectious diarrhea in an adult patient who is currently on anti-retroviral therapy
  • The patient has had a trial of one (1) Step-1 or Step-2 medication within the previous 180 days as evidenced by a previous paid claim under the prescription benefit administered by the plan